Reported results
- Cash, cash equivalents, and marketable securities were approximately $7.6 million as of September 30, 2026.
- Research and development expenses were approximately $1.6 million for the three months ended September 30, 2026.
- Loss from operations was approximately $5.4 million for the three months ended September 30, 2026 (GAAP).
- Loss from operations excluding the proposed settlement accrual was approximately $3.4 million for the three months ended September 30, 2026 (non-GAAP).
- Net income was approximately $0.7 million for the three months ended September 30, 2026 (GAAP).
Notes
The Company accrued $2.0 million for a proposed settlement as of September 30, 2026, which is included in general and administrative expenses for the three and nine months ended September 30, 2026. The Company noted substantial doubt about its ability to continue as a going concern.
Price and volatility reaction
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-18 (8-K, Item 2.02). Read the original filing on sec.gov.
